 Connection
Samuel Dominguez to Mycoplasma pneumoniae
This is a "connection" page, showing publications Samuel Dominguez has written about Mycoplasma pneumoniae.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.488 |
|
|
|
-
Park SW, Noble B, Howerton E, Nielsen BF, Lentz S, Ambroggio L, Dominguez S, Messacar K, Grenfell BT. Predicting the impact of non-pharmaceutical interventions against COVID-19 on Mycoplasma pneumoniae in the United States. Epidemics. 2024 Dec; 49:100808.
Score: 0.222
-
Olson D, Abbott J, Lin C, Prok L, Dominguez SR. Characterization of Children With Recurrent Episodes of Stevens Johnson Syndrome. J Pediatric Infect Dis Soc. 2017 Sep 01; 6(3):e140-e143.
Score: 0.134
-
Watkins LKF, Olson D, Diaz MH, Lin X, Demirjian A, Benitez AJ, Winchell JM, Robinson CC, Bol KA, Glodé MP, Dominguez SR, Miller LA, Kutty PK. Epidemiology and Molecular Characteristics of Mycoplasma pneumoniae During an Outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome. Pediatr Infect Dis J. 2017 06; 36(6):564-571.
Score: 0.132
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|